Keimyung University, abbreviated as KMU or Keimyung, is a private university located in Daegu, the fourth largest city in South Korea. The university takes roots from Jejungwon founded in 1899.

During the past decade, Keimyumg University Dongsan Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keimyumg University Dongsan Medical Center" #1 collaborator was "NRG Oncology" with 3 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Keimyumg University Dongsan Medical Center" are "Hepatitis B" (4 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Adenosquamous Cell Carcinoma" (1 trials), "Cervical Small Cell Carcinoma" (1 trials) and "Cervical Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Keimyumg University Dongsan Medical Center" in a lesser frequency.

Most popular intervention types in "Keimyumg University Dongsan Medical Center" are "Drug" (8 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clevudine" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Keimyumg University Dongsan Medical Center" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Keimyumg University Dongsan Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Keimyumg University Dongsan Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Keimyumg University Dongsan Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".